Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination
Cancer vaccines that make use of tumor antigens represent a promising therapeutic strategy by stimulating immune responses against tumors to generate long-term anti-tumor immunity. However, vaccines have shown limited clinical efficacy due to inefficient delivery. In this study, we focus on vaccine...
Saved in:
Main Authors: | Yuang Chen (Author), Yixian Huang (Author), Haozhe Huang (Author), Zhangyi Luo (Author), Ziqian Zhang (Author), Runzi Sun (Author), Zhuoya Wan (Author), Jingjing Sun (Author), Binfeng Lu (Author), Song Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages
by: Pearl Moharil, et al.
Published: (2022) -
Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer’s Disease
by: Wang X, et al.
Published: (2019) -
Folic Acid and PEI Modified Mesoporous Silica for Targeted Delivery of Curcumin
by: Xiaoxiao Sun, et al.
Published: (2019) -
Enhanced Tumor Accumulation of Low-Molecular-Weight Hyaluronic Acid/Chitosan Nanocomplexes for Photothermal Therapy
by: Gayoung Jo, et al.
Published: (2023) -
Derivatization in Analytical Chemistry
Published: (2022)